Julian S. Gangolli

Insider Reports History

Entity
Individual
Location
4955 Baseline Avenue, Santa Ynez, CA
Signature
/s/ Dwight Moxie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julian S. Gangolli:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Krystal Biotech, Inc. Director Stock Option (Right to Buy) 5K $410K $81.91 Jun 30, 2024 Direct
Krystal Biotech, Inc. Director Common Stock 0 $0 $165.76 May 20, 2024 Direct
Revance Therapeutics, Inc. Director Common Stock 0 $0 $3.65 Feb 6, 2025 Direct
Outlook Therapeutics, Inc. Director Stock Option (Right to Buy) 71.2K Oct 1, 2024 Direct
Revance Therapeutics, Inc. Director Stock Option (Right to buy) 23.5K May 1, 2024 Direct

Insider Reports Filed by Julian S. Gangolli

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVNC Revance Therapeutics, Inc. Feb 4, 2025 2 -$110K 4 Feb 6, 2025 Director
OTLK Outlook Therapeutics, Inc. Oct 1, 2024 2 $0 4 Oct 3, 2024 Director
KRYS Krystal Biotech, Inc. Jun 30, 2024 1 $0 4 Jul 1, 2024 Director
KRYS Krystal Biotech, Inc. May 20, 2024 5 -$2.83M 4 May 22, 2024 Director
RVNC Revance Therapeutics, Inc. May 1, 2024 2 $0 4 May 3, 2024 Director
OTLK Outlook Therapeutics, Inc. Mar 7, 2024 1 $0 4 Mar 8, 2024 Director
OTLK Outlook Therapeutics, Inc. Oct 4, 2023 1 $0 4 Oct 6, 2023 Director
KRYS Krystal Biotech, Inc. Jun 30, 2023 1 $0 4 Jul 3, 2023 Director
RVNC Revance Therapeutics, Inc. May 3, 2023 2 $0 4 May 5, 2023 Director
OTLK Outlook Therapeutics, Inc. Mar 29, 2023 1 $0 4 Mar 31, 2023 Director
OTLK Outlook Therapeutics, Inc. Oct 5, 2022 1 $0 4 Oct 7, 2022 Director
KRYS Krystal Biotech, Inc. Jun 30, 2022 1 $0 4 Jul 1, 2022 Director
RVNC Revance Therapeutics, Inc. May 4, 2022 1 $0 4/A May 13, 2022 Director
OTLK Outlook Therapeutics, Inc. Mar 23, 2022 1 $0 4 Mar 24, 2022 Director
OTLK Outlook Therapeutics, Inc. Oct 5, 2021 1 $0 4 Oct 7, 2021 Director
KRYS Krystal Biotech, Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director
RVNC Revance Therapeutics, Inc. May 5, 2021 2 $0 4 May 7, 2021 Director